Neal Flomenberg - Jun 27, 2025 Form 4 Insider Report for Tevogen Bio Holdings Inc. (TVGN)

Role: Chief Scientific Officer, Global R&D Lead
Signature: /s/ Kirti Desai, Attorney-in-Fact
Stock symbol: TVGN
Transactions as of: Jun 27, 2025
Transactions value $: $0
Form type: 4
Date filed: 7/1/2025, 04:49 PM
Previous filing: Mar 14, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Flomenberg Neal	Chief Scientific Officer, Global R&D Lead	C/O TEVOGEN BIO HOLDINGS INC., 15 INDEPENDENCE BLVD, STE 210, WARREN	/s/ Kirti Desai, Attorney-in-Fact	2025-07-01	0002011757

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TVGN	Common Stock	Award	$0	+300K	+8.34%	$0.00	3.9M	Jun 27, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on June 27, 2030, provided that the reporting person remains in service with the Issuer at such dates.

Remarks:

Chief Scientific Officer, Global R&D Lead